BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
7.87
+0.15 (1.94%)
At close: Sep 5, 2025, 4:00 PM
7.75
-0.12 (-1.52%)
After-hours: Sep 5, 2025, 7:43 PM EDT
BriaCell Therapeutics Employees
BriaCell Therapeutics had 16 employees as of July 31, 2023. The number of employees increased by 10 or 166.67% compared to the previous year.
Employees
16
Change
10
Growth
166.67%
Revenue / Employee
n/a
Profits / Employee
-$1,214,666
Market Cap
13.64M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jul 31, 2023 | 16 | 10 | 166.67% |
| Jul 31, 2021 | 6 | 0 | - |
| Aug 1, 2019 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BCTX News
- 11 days ago - BriaCell's Bria-OTS+™ Mechanism of Action Validated in Highly Rated Peer Reviewed Cancer Journal - GlobeNewsWire
- 12 days ago - BriaCell Awarded $2 Million NCI Grant to Advance Bria-PROS+™ in Prostate Cancer - GlobeNewsWire
- 15 days ago - BriaCell Announces Proposed Effective Date of Share Consolidation - GlobeNewsWire
- 24 days ago - BriaCell Selected for MSK's 2025 Therapeutics Accelerator Program for Bria-OTS+™ for Cancer - GlobeNewsWire
- 5 weeks ago - BriaCell Adds UCLA Health as Key Site in Pivotal Phase 3 Breast Cancer Study - GlobeNewsWire
- 5 weeks ago - BriaCell Awarded New Zealand Patent for its Whole Cell Technology - GlobeNewsWire
- 5 weeks ago - BriaCell's Subsidiary, BriaPro, Files Patent Application for Immuno-Oncology Platform with Novel Multitargeting Agents - GlobeNewsWire
- 6 weeks ago - BriaCell Announces Two Clinical Data Poster Presentations at ESMO 2025 - GlobeNewsWire